Connect with us

Health

WHO Names Nigeria’s Professor Martins Emeje Co-Chair of Traditional Medicine Advisory Group

The appointment of Professor Emeje reflects the WHO’s commitment to inclusive, balanced, and scientifically rigorous leadership in advancing traditional, complementary, and integrative medicine worldwide.

Published

on

448 Views

As the Director-General of NNMDA, Professor Emeje has played a pivotal role in promoting research, development, regulation, and commercialization of natural medicines in Nigeria.

The World Health Organisation (WHO) has named Professor Martins Emeje, Director-General of the Nigeria Natural Medicine Development Agency (NNMDA, as Co-Chair of its newly established Strategic and Technical Advisory Group on Traditional, Complementary and Integrative Medicine (STAG-TM).

Professor Emeje was appointed alongside Dr Susan Wieland, Director at Cochrane Complementary Medicine, following the formal unveiling of the Strategic and Technical Advisory Group.

The establishment of STAG-TM marks a significant milestone in the implementation of the WHO Traditional Medicine Strategy, aimed at strengthening global health systems through evidence-based traditional and integrative medicine.

The appointment of Professor Emeje reflects the WHO’s commitment to inclusive, balanced, and scientifically rigorous leadership in advancing traditional, complementary, and integrative medicine worldwide.

Both Co-Chairs bring extensive expertise in research, innovation, and policy development, particularly in natural products and evidence-based medicine.

As the Director-General of NNMDA, Professor Emeje has played a pivotal role in promoting research, development, regulation, and commercialization of natural medicines in Nigeria.

His selection highlights Nigeria’s growing contribution to global health governance and innovation in traditional medicine.

The Strategic and Technical Advisory Group on Traditional, Complementary and Integrative Medicine will provide expert guidance to the WHO on policy frameworks, research priorities, and best practices to ensure the safe, effective, and quality integration of traditional medicine into national healthcare systems.

The W.H.O while announcing the creation of the 19 member Group emphasized that the move is part of its global Traditional Medicine Strategy 2025 describing it as a decisive step in applying a scientific response to traditional medicine.

At the inaugural meeting of the Group, held alongside the second W. H.O Global Traditional Medicine Summit held in New Delhi, India, the W.H.O’s Assistant Director General for Health System,Access and Data, Dr Yukiko Nakatani says it is a pivotal moment for Traditional Medicine as it embodies cultural heritage, national health identities and a vital component of policy healthcare strategies.

The situation whereby the rapid growth of traditional medicine has not been matched by strong evidence, standards, regulatory frameworks or sustainable governance, W.H.O’s Chief Scientist , Dr Sylvie Briand emphasized, underscores the urgency of the initiative.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Gov Mbah Invest in world-class Enugu International Hospital

The hospital, equipped with state-of-the-art medical equipment and advanced digital and electronic systems, is expected to attract top medical professionals from Nigeria and around the world.

Published

on

By

156 Views

Enugu State Governor, Peter Mbah, says the Enugu International Hospital is designed to provide world-class healthcare services to people across all socioeconomic classes.

The Enugu International Hospital is located at Rangers Avenue, Independence Layout, Enugu.

Mbah stated this during a pre-launch tour of the facility ahead of its official commissioning.

The hospital, equipped with state-of-the-art medical equipment and advanced digital and electronic systems, is expected to attract top medical professionals from Nigeria and around the world.

The governor expressed satisfaction with the quality of the equipment installed at the facility, saying the investment would help position Enugu as a medical tourism hub in Nigeria.

He said the hospital would also help reduce the number of Nigerians travelling abroad for specialist medical treatment while creating an environment that would encourage Enugu-trained medical professionals to return home.

According to Mbah, several Enugu-qualified medical practitioners based abroad have already reached out to express interest in working at the international hospital and contributing to the development of the state’s health sector.

The governor further said the facility would create job opportunities for medical graduates, healthcare professionals and other workers, with the potential to boost economic activity in the state.

During the tour, Mbah inspected several specialist units, including the Precision Oncology and Nuclear Medicine Unit, specialised surgery theatres, intensive care units, advanced diagnostics and imaging, and renal care and dialysis facilities.

He also toured the cancer, heart and vascular, nuclear medicine and molecular imaging, neuroscience, and renal centres.

Accompanied by the Director of the facility, Professor Sam Agwu, and other specialists, the governor received briefings on the various services and specialist care the hospital is expected to provide.

The Enugu International Hospital operates as a comprehensive quaternary care facility with more than 300 beds and was established to provide world-class specialist healthcare.

The facility is expected to strengthen access to advanced medical care, support medical professionals, create employment and contribute to Enugu State’s emergence as a destination for medical tourism.

Continue Reading

Health

Bayer to establish reproductive health commodities plant in Nigeria

The plant is expected to manufacture family planning commodities locally, reducing Nigeria’s dependence on imported products, creating jobs and contributing to economic growth.

Published

on

By

161 Views

•The Minister of Health and Social Welfare, Prof. Muhammad Pate

Global pharmaceutical company, Bayer, is to establish a reproductive health commodities manufacturing plant in Nigeria, with the facility currently under construction in Anambra State.

The plant is expected to manufacture family planning commodities locally, reducing Nigeria’s dependence on imported products, creating jobs and contributing to economic growth.

The Minister of Health and Social Welfare, Prof. Muhammad Pate, disclosed this in Abuja at the inauguration of the High-Level Inter-Ministerial Platform (IMP) on Family Planning, Health, Human Capital and Sustainable National Development.

Pate described the investment as evidence that President Bola Tinubu’s Executive Order on the pharmaceutical sector was beginning to attract significant investments in local pharmaceutical manufacturing, diagnostics and health technology.

Also speaking, the Managing Director of FP2030 West and Central Africa Office, Dr Alain Damiba, described the initiative as a major step towards strengthening cross-sector collaboration to improve health outcomes and accelerate Nigeria’s socio-economic development.

Damiba commended the Federal Government for adopting a whole-of-government approach, noting that the new platform demonstrated that health and family planning were national development priorities and not issues that should be left to the health sector alone.

“Health, including family planning, is a smart investment in human capital and Nigeria’s future,” Damiba said.

Source: The Guardian Nigeria

Continue Reading

Health

Medical Oxygen Killing More Than 600,000 Nigerians Annually

The project started its first phase by carrying out intervention work in three industrial areas of the state: quarry industrial site in Onueke, rice mill in Abakaliki, and timber market

Published

on

By

164 Views

•Professor Jesse Uneke

The Vice Chancellor of David Umahi Federal University of Health Sciences (DUFUS), Ebonyi State, Professor Jesse Uneke, has estimated that more than 600,000 Nigerians died yearly due to issues relating to the administration of medical oxygen.

Uneke, who is the Nigerian and State Lead/Principal Investigator for the EQUI-RESP Africa Research Project, disclosed this in Abakaliki, during the First Stakeholders’ Engagement Event/Co-Creation Workshop on Medical Oxygen Economy organised by the university in conjunction with the University of Edinburgh, UK, supported by the National Institute for Health and Research (NIHR), UK.

He explained that the administration of medical oxygen issues was happening because there was no platform where stakeholders in the medical oxygen space could come together to discuss the research-policy interface and see how to contextualise some of the strategies against the problems for the country.

“That is why, in this phase of this project, we have decided to start with this kind of stakeholders’ engagement. I am excited that we have every key stakeholder in the medical oxygen space represented here,” Uneke said.

He opined that the project started its first phase by carrying out intervention work in three industrial areas of the state: quarry industrial site in Onueke, rice mill in Abakaliki, and timber market.

This project has to do with respiratory health, and the idea is to come up with strategies that will lead to interventions that will improve health outcomes as far as respiratory health is concerned.

Continue Reading

Trending